|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
24.63(B) |
Last
Volume: |
809,280 |
Avg
Vol: |
1,121,014 |
52
Week Range: |
$147.37 - $190.58 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 226 |
Guru Rank Value : 6.9 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
53,186 |
54,934 |
202,143 |
255,201 |
Total Sell Value |
$9,647,535 |
$9,954,335 |
$34,146,908 |
$41,865,527 |
Total People Sold |
3 |
4 |
8 |
8 |
Total Sell Transactions |
9 |
11 |
29 |
39 |
End Date |
2025-07-13 |
2025-04-11 |
2024-10-11 |
2023-10-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-26 |
4 |
AS |
$187.22 |
$42,706 |
D/D |
(227) |
38,117 |
|
-3% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-26 |
4 |
OE |
$103.57 |
$23,510 |
D/D |
227 |
38,344 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-24 |
4 |
AS |
$187.02 |
$32,729 |
D/D |
(175) |
38,117 |
|
-1% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-24 |
4 |
OE |
$103.57 |
$18,125 |
D/D |
175 |
38,292 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-23 |
4 |
AS |
$187.12 |
$5,293,313 |
D/D |
(28,288) |
38,117 |
|
-2% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-23 |
4 |
OE |
$103.57 |
$2,929,788 |
D/D |
28,288 |
66,405 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-21 |
4 |
AS |
$185.00 |
$365,375 |
D/D |
(1,975) |
15,269 |
|
0% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-19 |
4 |
AS |
$183.00 |
$829,356 |
D/D |
(4,532) |
17,244 |
|
1% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-19 |
4 |
OE |
$112.17 |
$508,354 |
D/D |
4,532 |
21,776 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-15 |
4 |
AS |
$180.00 |
$355,500 |
D/D |
(1,975) |
17,244 |
|
2% |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-08-13 |
4 |
D |
$175.91 |
$21,637 |
D/D |
(123) |
8,338 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-06 |
4 |
AS |
$175.00 |
$968,625 |
D/D |
(5,535) |
19,219 |
|
6% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-06 |
4 |
OE |
$86.63 |
$308,403 |
D/D |
3,560 |
24,745 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-07-31 |
4 |
AS |
$170.00 |
$375,700 |
D/D |
(2,210) |
8,450 |
|
10% |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-07-30 |
4 |
AS |
$167.40 |
$1,384,231 |
D/D |
(8,269) |
10,660 |
|
9% |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-07-30 |
4 |
OE |
$86.63 |
$849,764 |
D/D |
8,269 |
15,884 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-07-21 |
4 |
A |
$167.49 |
$2,847 |
D/D |
17 |
7,515 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-07-21 |
4 |
A |
$167.49 |
$13,400 |
D/D |
80 |
21,185 |
|
- |
|
Carter Robert B |
Director |
|
2025-07-21 |
4 |
A |
$167.51 |
$1,173 |
D/D |
7 |
2,692 |
|
- |
|
Lassiter Wright Iii |
Director |
|
2025-07-21 |
4 |
A |
$167.51 |
$1,173 |
D/D |
7 |
9,044 |
|
- |
|
Samad Samer Abdul |
Executive Vice President & CFO |
|
2025-07-21 |
4 |
A |
$167.50 |
$12,060 |
D/D |
72 |
25,673 |
|
- |
|
Gregg Vicky B |
Director |
|
2025-07-21 |
4 |
A |
$167.50 |
$13,232 |
D/D |
79 |
18,217 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-07-21 |
4 |
A |
$167.50 |
$4,522 |
D/D |
27 |
10,660 |
|
- |
|
Samad Samer Abdul |
Executive Vice President & CFO |
|
2025-07-16 |
4 |
D |
$169.01 |
$143,659 |
D/D |
(850) |
25,601 |
|
- |
|
Gregg Vicky B |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
18,138 |
|
- |
|
820 Records found
|
|
Page 1 of 33 |
|
|